Covington News

 

 

CounterPath Lists on NASDAQ

July 11, 2012

New York - July 11, 2012 - CounterPath Corporation (the “Company”) commenced trading on the NASDAQ Capital Market under the symbol “CPAH”. The stock is also traded on the TSX under the symbol “CCV”.

The Company’s listing on NASDAQ, which closely followed the completion of a successful (CDN)$3.66 million private placement in June of this year, underscores CounterPath’s steady growth since its inception in 2002.

Covington Strategic Capital Fund Inc. Series I and Series II Announce That Class A Shares Will No Longer Be Offered For Subscription

December 14, 2011

Covington Capital Corporation and the Board of Directors for Covington Strategic Capital Fund Inc. (the “Fund”) today announced that effective December 19, 2011 the Funds will no longer offer Class A shares for sale to either new or existing investors.

Covington Venture Fund Receives Shareholder Approval for Consolidation of Class A Shares Series I, II, III Assets with Class A Shares Series IV Assets and Class A Share Series V Assets

December 6, 2011

Covington Capital Corporation, the manager of Covington Venture Fund Inc. (the “Fund”) announced that at the annual and special meeting of shareholders of the Fund completed on December 16, 2011, shareholders passed a special resolution approving the consolidation of the pool of assets owned for holders of Class A Shares Series I, II, III (“Series I, II, III Assets”) with the pool of assets owned for holders of Class A Shares Series IV (the “Series IV Assets”) and the pool of assets owned for holders of Class A Shares Series V (“the “Series V Assets”).

Covington Acquisition of VenGrowth and New Generation Biotech (Equity) Funds Successfully Closes

September 6, 2011

Covington Capital Corporation and the VenGrowth Funds today announced the successful closing of the transaction by which Covington Fund II Inc. acquired the assets of New Generation Biotech (Equity) Fund Inc. (“NGBE) and The VenGrowth Investment Fund Inc., The VenGrowth II Investment Fund Inc., The VenGrowth III Investment Fund Inc., The VenGrowth Advanced Life Sciences Fund Inc., and The VenGrowth Traditional Industries Fund Inc. (collectively the “Funds”).

Covington Fund II Inc. Shareholders Approve Purchase of Assets of the VenGrowth Investment Funds and New Generation Biotech (Equity) Fund Inc.

August 25, 2011

Covington Capital Corporation (“Covington”) announced today that as part of the Covington Fund II Inc. (the “Fund”) special meeting, shareholders of the Fund approved the purchase of assets (the “Acquisition”) of The VenGrowth Investment Fund Inc., The VenGrowth II Investment Fund Inc., The VenGrowth III Investment Fund Inc., The VenGrowth Advanced Life Sciences Fund Inc., and The VenGrowth Traditional Industries Fund Inc. (collectively the “VenGrowth Funds”) and New Generation Biotech (Equity) Fund Inc. (“NGBE”) in exchange for Class A shares of the Fund.

Pages